The prescription opioid epidemic in a nutshell

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
I began believing in the late 1990s my patients were compliant since they self reported no aberrations, and had 3 month visits. I began UDS testing without confirmatory testing initially and found many aberrancies, but part of these could be explained by inaccuracy in the testing. Out of concerns from this I moved to bimonthly visits. Then I started asking about specifics such as any hospital visits, falls, use of alcohol, cocaine, marijuana or other illicits ANY TIME DURING THE MONTH. It was eye opening. I then lowered my prescribing interval from two months to monthly and instituted UDS with confirmatory testing. Even with all our rules and regulations, 20% of the patients each month were abusing drugs. Jettisoned more and more patients, while tightening up my requirements to accept any patient, and would not accept anyone out of state, then eventually anyone outside of the area. PMP access eventually became available and was initially checked once a year, then later once every 3 months, then once a month. Added mandatory direct fax of prior prescribers history and progress notes before I would even make an appointment for those wanting to see me, and screened out over 50% of those who would have otherwise been given an initial appointment. There were some doozies of doctor shoppers that were caught in this manner and they were quickly kicked out of the practice. Instead of rare UDS, I increased this to targeted UDS plus at least yearly UDS. Kicked out more patients. Began working with local police departments notifying them of diversion of drugs and some departments reciprocated notifying me about patients that were running off the road DUI, crashing, injuring others, and in rare cases about those who were known to be selling drugs. Then I added alcohol testing- found 25% of my patients were actively drinking alcohol in spite of clinic rules specifically stating possible discharge under such conditions- they did not care. Patients will do whatever they damned well please despite all the clinic rules, all the CDC guidelines, and regardless of the risk to your medical license and medical practice. They may use cocaine in week one or two after being seen in your clinic. They may have sold most of the drug by the end of the first week, as I found out when I instituted mandatory pill counts between visits discovering only 30% had at least as many pills as expected. Jettison more patients. Finally I had enough and jettisoned all patients receiving opioids.

So........no, I am no longer helping the chronic pain population by being a "compassionate" doctor any longer, nor am I fulfilling my desire to help people with chronic pain by using all means necessary or available. The upside is that I have selected out treatment options that do not require me to herd cats or involve myself with unsavory, potentially dangerous chemically dependent patients (re: addicts). There is just too much overlap in the Venn diagrams of the legitimate compliant pain population that would benefit from opioids, those who are out of control with their use of opioids or engage in illicits/alcohol use at the same time as opioids, and the population diverting opioids. My time as a physician is better spent helping those I can help rather than trying to determine who is scamming me, who may overdose, and who may become violent if they don't get their candy. When added to the pressures from state attorney generals, threats of litigation from families should a patient die while taking opioids, medical board actions, county civil suite actions, and push back by every branch of government, I found it impossible to continue prescribing opioids. My conclusion is that whereas opioids are a viable option for a few patients, at least 80% of those being prescribed opioids should not be receiving them since they pose a threat to themselves and to society. In order to prescribe opioids, an elaborate screening and compliance program is needed, requiring significant number of hours and effort to keep the practice clean, but even then if we look hard enough (alcohol testing of urine, pill counts throughout the month) we find we are being scammed. The majority of the general population who would seek opioids from pain doctors are indeed addicts, engage in dangerous practices with drugs, or are diverting drugs for sale or trade. I haven't the patience nor the time left in my career trying to weed out the majority those seeking opioids that could easily end my career through no fault of my own. The risks of opioid prescribing are far too high to many patients and the benefits are too low for even a few patients to continue this dangerous game of roulette.

Re-posted for everyone's viewing pleasure- the greatest comment of all time from the great one himself, Algos. His thoughts on opioids from spring, 2018


Not having all those policies and procedures in place before starting a clinic is dangerous.

Members don't see this ad.
 
Public Release: 1-Aug-2018
Number of opioid prescriptions remains unchanged, Mayo Clinic research finds
Mayo Clinic





ROCHESTER, Minn. - Despite increased attention to opioid abuse, prescriptions have remained relatively unchanged for many U.S. patients, research led by Mayo Clinic finds. The research, published in The BMJ, shows that opioid prescription rates have remained flat for commercially insured patients over the past decade. Rates for some Medicare patients are leveling but remain above where they were 10 years ago.

MULTIMEDIA ALERT: Video and audio are available for download on the Mayo Clinic News Network.

"Our data suggest not much has changed in prescription opioid use since about five years ago," says Molly Jeffery, Ph.D., lead author, who is the scientific director of the Mayo Clinic Division of Emergency Medicine Research.

A cross-specialty team of physicians and researchers from Mayo Clinic, Yale University, The University of Alabama at Birmingham and Dartmouth College collaborated to study 48 million U.S. patients who had insurance coverage between 2007 and 2016. Using deidentified insurance claims from the OptumLabs Data Warehouse, the team compared opioid prescriptions among commercially insured patients; Medicare Advantage recipients 65 and older; and Medicare Advantage beneficiaries younger than 65, who generally qualify because of long-term disability. They found that over the course of one year, 14 percent of commercially insured patients, 26 percent of Medicare Advantage patients 65 and older, and 52 percent of disabled Medicare Advantage patients received an opioid prescription.

Over the 10-year period, disabled Medicare Advantage recipients had the highest rates of use and proportion of long-term use, and the largest average daily dose. For that group, quarterly opioid use was lowest in 2007 at 26 percent, peaked in 2013 at 41 percent, and was 39 percent in 2016. The average daily dose increased from the equivalent of seven pills of 5-milligram oxycodone to a high of about nine pills in 2012. In 2016, it went back to roughly eight pills.

Among Medicare Advantage recipients 65 and older, quarterly opioid use was lowest at the start of the study period in 2007 (11 percent), increased to 15 percent in 2010, and decreased to 14 percent by the end of the 10-year period. The average daily dose, roughly three pills of 5-milligram oxycodone, remained relatively unchanged for this group.

For commercial patients, quarterly opioid use remained relatively flat at 6-7 percent for the study period, and the average daily dose, which is the equivalent of about two pills of 5-milligram oxycodone, remained the same for that group, as well.

"Based on these historical trends, there remains an unmet patient need to better target the use of prescription opioids," says W. Michael Hooten, M.D., co-author, who is a Mayo Clinic anesthesiologist and pain specialist.

The Centers for Disease Control and Prevention (CDC) has previously reported that opioid prescriptions in the U.S. increased dramatically from 1999 to 2010. The CDC says those numbers decreased from 2011 to 2015, but the 2015 total was still three times higher than the 1999 total and four times higher than amount prescribed per capita in Europe.

However, Mayo research finds that while prescriptions are leveling off, they're not decreasing in most groups.

"Our research of patient-level data doesn't show the decline that was found in previous research," Dr. Jeffery says. "Those declines were seen in the total amount of opioids prescribed across the whole market. We wanted to know how the declines were experienced by individual people. Did fewer people have opioid prescriptions? Did people taking opioids take less over time? When we looked at it that way, we found a different picture."

Adding to the urgency of addressing this issue is the steadily increasing number of deaths in the U.S. attributed to opioid overdoses. From 1999 to 2014, overdose deaths increased by 200 percent, and by 28 percent from 2015 to 2016 alone, according to the CDC.

The new Mayo research also shows:

  • Over the 10-year period, disabled Medicare Advantage recipients had an average daily opioid dose equaling about nine pills of 5-milligram oxycodone, compared to about three pills for Medicare Advantage recipients 65 and older, and about two pills for commercially insured patients.
  • Long-term opioid use made up 3 percent of commercial patients, 7 percent of Medicare Advantage recipients 65 and older, and 14 percent of the disabled Medicare Advantage recipients. However, this small group of patients made up the majority of total opioid pills dispensed: 62 percent for commercial; 70 percent for Medicare Advantage 65 and older; and 89 percent for disabled Medicare Advantage.
Commercially insured patients made up about 89 percent of those studied, while about 10 percent were Medicare Advantage recipients 65 and older, and less than 2 percent were disabled Medicare Advantage recipients. The study did not include people with Medicaid insurance, those covered by the Veterans Affairs or Tricare (military insurance), or the uninsured.

Mayo Clinic is broadly researching opioid prescribing practices to find ideal doses for individual patient needs. The researchers say the goal is to achieve the best possible patient outcomes and experience with minimal exposure to opioids. This research has been translated into opioid prescribing guidelines and tools for medical practices at Mayo and beyond, identifying patients who may not need opioids and, in some cases, cutting prescriptions in half.

###

Dr. Jeffery is a health care practice and policy researcher in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. The study's senior author is Nilay Shah, Ph.D., the center's deputy director for research.

This research was made possible by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. The researchers used the OptumLabs Data Warehouse, which contains deidentified administrative claims data, including medical claims and eligibility information from a large national U.S. health insurance plan, as well as electronic health record data from a nationwide network of provider groups.

The researchers report no conflicts of interest.

About the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery The Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery seeks to discover new ways to improve health; translate those discoveries into evidence-based, actionable treatments, processes and procedures; and apply this new knowledge to improve care for patients everywhere. Learn more about the center.

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, comprehensive care to everyone who needs healing. Learn more about Mayo Clinic. Visit the Mayo Clinic News Network.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

to summarize -
1. while all groups had decreases in opioid prescribing, all groups are still being prescribed more than in 2010.
2. certain groups - or, more specifically, ONE specific group - get the most opioids and at the highest doses. they make up for the significant amount of opioid prescribing.

hint, its not the commercial payor group...



in my opinion, we should be limiting new prescribing, and doubly especially for Medicare Advantage patients under age 65 (which is probably the most vulnerable population group with most significant life limiting illnesses)



(Legacy patients and what to do with them remain a completely different topic of discussion)
 
to summarize -
1. while all groups had decreases in opioid prescribing, all groups are still being prescribed more than in 2010.
2. certain groups - or, more specifically, ONE specific group - get the most opioids and at the highest doses. they make up for the significant amount of opioid prescribing.

hint, its not the commercial payor group...



in my opinion, we should be limiting new prescribing, and doubly especially for Medicare Advantage patients under age 65 (which is probably the most vulnerable population group with most significant life limiting illnesses)



(Legacy patients and what to do with them remain a completely different topic of discussion)

F1.large.jpg



"Based on these historical trends, there remains an unmet patient need to better target the use of prescription opioids," says W. Michael Hooten, M.D., co-author, who is a Mayo Clinic anesthesiologist and pain specialist."

Mike Hooten is a smart guy: Triple boarded psych, IM, and anesthesia. Then did a pain fellowship...
 
Last edited:
  • Like
Reactions: 1 users
Members don't see this ad :)
https://www.medical-hypotheses.com/article/S0306-9877(18)30337-2/fulltext

We may be preprogrsmming ourselves to the opioid epidemic... interesting medical hypothesis:


A plausible causal relationship between the increased use of fentanyl as an obstetric analgesic and the current opioid epidemic in the US




Kajsa Brimdyr

Email the author Kajsa Brimdyr,
Karin Cadwell
Healthy Children Project, Inc., 327 Quaker Meeting House Road, East Sandwich, MA 02537, United States



Love the correlation, and upon further study....
bananas.jpeg




superbowl points.jpeg
 
those 2 studies are coincidental statistics with no correlation. this is a false statement.

the fallacy in both graphs is it states that there is correlation, as in mutual relationship and connection. just because 2 graphs look alike does not imply that it correlates.

the hypothesis - and it is purely that - may have a scientific basis - exposing newborns to fentanyl. similar to data suggesting exposing newborns to alcohol predisposes to ethanol abuse in adults.
 
those 2 studies are coincidental statistics with no correlation. this is a false statement.

the fallacy in both graphs is it states that there is correlation, as in mutual relationship and connection. just because 2 graphs look alike does not imply that it correlates.

the hypothesis - and it is purely that - may have a scientific basis - exposing newborns to fentanyl. similar to data suggesting exposing newborns to alcohol predisposes to ethanol abuse in adults.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC

Nah.
 
Opioids delay healing of spinal fusion: a rabbit posterolateral lumbar fusion model. - PubMed - NCBI

Opioids delay healing of spinal fusion: a rabbit posterolateral lumbar fusion model.
Jain N1, Himed K2, Toth JM3, Briley KC4, Phillips FM5, Khan SN6.
Author information
1
Department of Orthopaedics, The Ohio State University Wexner Medical Center, 376 W 10th Ave, Columbus, OH 43210, USA.
2
The Ohio State University School of Medicine, 376 W 10th Ave, Columbus, OH 43210, USA.
3
Department of Orthopaedics, Medical College of Wisconsin, 8701 W Watertown Plank Rd, Milwaukee, WI 53226, USA.
4
Department of Radiology, Wright Center for Innovation and Biomedical Imaging, The Ohio State University Wexner Medical Center, 395 W 12th Ave, Columbus, OH 43210, USA.
5
Midwest Orthopaedics at Rush, Rush University Medical Center, 1611 W Harrison St, Chicago, IL 60612, USA.
6
Department of Orthopaedics, The Ohio State University Wexner Medical Center, 376 W 10th Ave, Columbus, OH 43210, USA. Electronic address: [email protected].
Abstract
BACKGROUND CONTEXT:
Opioid use is prevalent in the management of pre- and postoperative pain in patients undergoing spinal fusion. There is evidence that opioids downregulate osteoblasts in vitro, and a previous study found that morphine delays the maturation and remodeling of callus in a rat femur fracture model. However, the effect of opioids on healing of spinal fusion has not been investigated before. Isolating the effect of opioid exposure in humans would be limited by the numerous confounding factors that affect fusion healing. Therefore, we have used a well-established rabbit model to study the process of spinal fusion healing that closely mimics humans.

PURPOSE:
The objective of this work was to study the effect of systemic opioids on the process of healing of spinal fusion in a rabbit posterolateral spinal fusion model.

STUDY DESIGN/SETTING:
This is a preclinical animal study.

MATERIALS AND METHODS:
Twenty-four adult New Zealand white rabbits were studied in two groups after approval from the Institutional Animal Care and Use Committee (IACUC). The opioid group (n=12) received 4 weeks' preoperative and 6 weeks' postoperative transdermal fentanyl. Serum fentanyl levels were measured just before surgery and 4 weeks postoperatively to ensure adequate levels. The control group (n=12) received only perioperative pain control as necessary. All animals underwent a bilateral L5-L6 posterolateral spinal fusion using iliac crest autograft. Animals were euthanized at the 6-week postoperative time point, and assessment of fusion was done by manual palpation, plain radiographs, microcomputed tomography (microCT), and histology.

RESULTS:
Twelve animals in the control group and 11 animals in the opioid group were available for analysis at the end of 6 weeks. The fusion scores on manual palpation, radiographs, and microCT were not statistically different. Three-dimensional microCT morphometry found that the fusion mass in the opioid group had a lower bone volume (p=.09), a lower trabecular number (p=.02), and a higher trabecular separation (p=.02) compared with the control group. Histologic analysis found areas of incorporation of autograft and unincorporated graft fragments in both groups. In the control group, there was remodeling of de novo woven bone to lamellar organization with incorporation of osteocytes, formation of mature marrow, and relative paucity of hypertrophied osteoblasts lining new bone. Sections from the opioid group showed formation of de novo woven bone, and hypertrophied osteoblasts were seen lining the new bone. There were no sections showing lamellar organization and development of mature marrow elements in the opioid group. Less dense trabeculae on microCT correlated with histologic findings of relatively immature fusion mass in the opioid group.

CONCLUSIONS:
Systemic opioids led to an inferior quality fusion mass with delay in maturation and remodeling at 6 weeks in this rabbit spinal fusion model. These preliminary results lay the foundation for further research to investigate underlying cellular mechanisms, the temporal fusion process, and the dose-duration relationship of opioids responsible for our findings.

Copyright © 2018 Elsevier Inc. All rights reserved.

only negatives about this study:
1. rabbit model, so unknown if it truly translates to humans
2. who knew that rabbits had 6 (actually, 7) lumbar vertebrae?
3. the study was done at the Ohio State University, so one naturally has a momentary pause to wonder about truthfulness.....
 
  • Like
Reactions: 1 users
maybe we will be doing genetic testing in the future - on opioid "candidates" prior to prescribing...

Human Endogenous Retrovirus-K HML-2 integration within RASGRF2 is associated with intravenous drug abuse and modulates transcription in a cell-line model

Human Endogenous Retrovirus-K HML-2 integration within RASGRF2 is associated with intravenous drug abuse and modulates transcription in a cell-line model
Timokratis Karamitros, Tara Hurst, Emanuele Marchi, Eirini Karamichali, Urania Georgopoulou, Andreas Mentis, Joey Riepsaame, Audrey Lin, Dimitrios Paraskevis, Angelos Hatzakis, John McLauchlan, Aris Katzourakis, and Gkikas Magiorkinis
PNAS published ahead of print September 24, 2018 https://doi.org/10.1073/pnas.1811940115
Add to Cart ($10)

Significance
The human genome is “littered” with remnants of ancient retrovirus infections that invaded the germ line of our ancestors. Only one of these may still be proliferating, named HERV-K HML-2 (HK2). Not all humans have the same HK2 viruses in their genomes. Here we show that one specific uncommon HK2, which lies close to a gene involved in dopaminergic activity in the brain, is more frequently found in drug addicts and thus is significantly associated with addiction. We experimentally show that HK2 can manipulate nearby genes. Our study provides strong evidence that uncommon HK2 can be responsible for unappreciated pathogenic burden, and thus underlines the health importance of exploring the phenotypic roles of young, insertionally polymorphic HK2 integrations in human populations.

Abstract
HERV-K HML-2 (HK2) has been proliferating in the germ line of humans at least as recently as 250,000 years ago, with some integrations that remain polymorphic in the modern human population. One of the solitary HK2 LTR polymorphic integrations lies between exons 17 and 18 of RASGRF2, a gene that affects dopaminergic activity and is thus related to addiction. Here we show that this antisense HK2 integration (namely RASGRF2-int) is found more frequently in persons who inject drugs compared with the general population. In a Greek HIV-1–positive population (n = 202), we found RASGRF2-int 2.5 times (14 versus 6%) more frequently in patients infected through i.v. drug use compared with other transmission route controls (P = 0.03). Independently, in a United Kingdom-based hepatitis C virus-positive population (n = 184), we found RASGRF2-int 3.6 times (34 versus 9.5%) more frequently in patients infected during chronic drug abuse compared with controls (P < 0.001). We then tested whether RASGRF2-int could be mechanistically responsible for this association by modulating transcription of RASGRF2. We show that the CRISPR/Cas9-mediated insertion of HK2 in HEK293 cells in the exact RASGRF2 intronic position found in the population resulted in significant transcriptional and phenotypic changes. We also explored mechanistic features of other intronic HK2 integrations and show that HK2 LTRs can be responsible for generation of cis-natural antisense transcripts, which could interfere with the transcription of nearby genes. Our findings suggest that RASGRF2-int is a strong candidate for dopaminergic manipulation, and emphasize the importance of accurate mapping of neglected HERV polymorphisms in human genomic studies.
 
  • Like
Reactions: 1 user
the nursing board of course refused to take responsibility for NP actions on themselves as a profession, but instead blamed the physician. nice.

fwiw, wonder if she got a break for testifying against MD...
 
Members don't see this ad :)
Why in TF would you NOT sign up?
 
US leads developed nations in drug overdose deaths

US leads developed nations in drug overdose deaths

Chen Y, et al. Ann Intern Med. 2018;doi:10.7326/M18-2415.

November 12, 2018

Please provide your email address to receive an email when new articles are posted on Internal Medicine: Addiction.

Receive an email when new articles are posted on Internal Medicine: Addiction.
You have already added Internal Medicine: Addiction to your email alerts.

Click here to manage your alerts.
The rate of premature drug overdose mortality was the highest in the United States, compared with several other developed nations, according to a study published in Annals of Internal Medicine.

“Drug overdose mortality rates in the United States have more than doubled during the 21st century, reaching an estimated 63,632 deaths in 2016,” Yingxi Chen, MD, PhD, postdoctoral fellow at the National Cancer Institute, and colleagues wrote. “Recent increases have also been reported in other high-income countries, raising concerns that the problem has grown internationally.”


See Also
Chen and colleagues examined data from the WHO mortality database to investigate how many deaths due to drug overdoses occurred between 2001 and 2015 by country, year, age and sex. The researchers used the International Classification of Diseases, 10th Revision, codes for mental and behavioral disorders due to substance use and poisoning by external causes and poisoning of undetermined intent to define overdose death.

Only countries with fewer than 10% of drug overdose deaths coded as poisoning of undetermined intent were included. Thirteen countries were eligible for the analysis, including the U.S., Australia, Chile, Denmark, England, Wales, Estonia, Finland, Germany, Mexico, the Netherlands, Norway and Spain.

To concentrate on premature mortality, only individuals aged 20 to 64 years were included.

Data showed that in 2015, the rate of drug overdose mortality for both men and women were highest in the U.S. (35 deaths per 100,000 men; 20 deaths per 100,000 women) and lowest in Mexico (1 death per 100,000 men; 0.2 deaths per 100,000 women). There was a substantial variation in mortality trends by country.

Between 2001 and 2015, Estonia had the highest average annual percentage of change in the rates of drug overdose mortality (6.9% in men; 7.9% in women) and the United States had the second highest average change (4.3% in men; 5.3% in women). The drug overdose mortality rates also increased in Australia and the Netherlands.

Conversely, Norway had high mortality rates but demonstrated the greatest decline in drug overdose mortality in both men (average annual percentage of change = –3.2%) and women (average annual percentage of change = –2%). Mexican men and women, Spanish men and Danish women showed significant decreases in the rate of overdose mortality. Overall, men aged 35 to 49 years and women aged 50 to 64 years had the highest rates of mortality.

“Our data highlight the severity of the drug overdose epidemic in the United States, which has premature mortality rates more than twice those of any other country studied, although worrisome trends were also observed in men and women in 5 of the 13 countries studied between 2001 and 2015,” Chen and colleagues concluded. “Of note, decreases were also observed in several countries.”

“Urgent public action is needed, as are improvements in maintaining the quality of systems and data,” they added. “Detailed evaluations of the policies of countries with declining rates may help identify approaches that can be applied elsewhere to prevent further premature deaths.” – by Alaina Tedesco



(actual link below)
Premature Mortality From Drug Overdoses: A Comparative Analysis of 13 Organisation for Economic Co-operation and Development Member Countries With High-Quality Death Certificate Data, 2001 to 2015 | Annals of Internal Medicine | American College of Physicians
 
Last edited:
Charged in the indictment are:

• Dr. Eric Backos, 65, of Bloomfield Hills

• Dr. Ganiu Edu, 50, of Southfield

• Dr. David Lewis, 41, of Detroit

• Dr. Christopher Russo, 50, of Birmingham

• Dr. Ronald Kufner, 68, of Ada
 
Charged in the indictment are:

• Dr. Eric Backos, 65, of Bloomfield Hills

• Dr. Ganiu Edu, 50, of Southfield

• Dr. David Lewis, 41, of Detroit

• Dr. Christopher Russo, 50, of Birmingham

• Dr. Ronald Kufner, 68, of Ada

https://www.thepaincenterusa.com/our-staff

"Bothra has practiced in Warren for 30 years, during which he made a name for himself as an accomplished physician, philanthropist and political insider. According to India Today magazine, he was appointed as co-chairman of the Asian-American Coalition for the U.S. presidential election in 1988."
 
Okay...please explain how you get to the number $500 million...
 
More info.
 

Attachments

  • indicted_doctors.pdf
    1.4 MB · Views: 109
there must be something else to it. the procedures don't seem excessive, the dosages of the pills are not out of the ordinary or excessive (ie hydrocodone 120 pills for a month).

13 million doses sounds excessive.

but, 6 doctors x 5 years x 12 months = 360.

as an example, those 6 doctors, if they had 400 patients with, say, cancer pain or failed back, and got monthly tramadol prescriptions, would amount to 360x400x120= 17.3 million doses of opioids...

there is a fair amount of DME.
 
Last edited:
there must be something else to it. the procedures don't seem excessive, the dosages of the pills are not out of the ordinary or excessive (ie hydrocodone 120 pills for a month).

13 million doses sounds excessive.

but, 6 doctors x 5 years x 12 months = 360.

as an example, those 6 doctors, if they had 400 patients with, say, cancer pain or failed back, and got monthly tramadol prescriptions, would amount to 360x400x120= 17.3 million doses of opioids...

there is a fair amount of DME.
I've had some patients come to me and tell them that other doctors they've seen, told them, "If you don't do these procedures, I won't prescribe you the opiates you want." Patient then says, "I've had all those exact same procedures, none of them worked." Then the doc doubles down with, "If you don't do these procedures, I won't prescribe you the opiates you want." If the patient agrees, then the doc in question has essentially admitted to trading opiates, for payment for unnecessary, futile and fraudulent care.

Now, it doesn't mean you have to prescribe them the opiates. If you feel the patient is manipulating to get opiates, and that opiates are futile and unnecessary along with the procedures that the patient feels are futile and unnecessary, then fine. But coercing patients to undergo procedures they're telling you are are futile.....Not good.

It sounds like it could be something like that. If they have reports of something like that from patients or staff, then they may have a case. Maybe there's more to it than that, I don't know.
 
Last edited:
would make more sense. I don't know anyone else who got in trouble for billing a 64635, for example, unless there is fraud that we are not seeing .

I am seeing a pattern - im wondering if they were set up with fake patients. out of the 56 listed instances, there are only really 6 sets of initials that are listed in the indictment.

ie: Patient DS, Patient GR, Patient VL, Patient MG, Patient JG, Patient JL.

(otherwise, only other patients are 2 prescriptions for Patient AP, an appointment and DME for Patient UC).
 
would make more sense. I don't know anyone else who got in trouble for billing a 64635, for example, unless there is fraud that we are not seeing .

I am seeing a pattern - im wondering if they were set up with fake patients. out of the 56 listed instances, there are only really 6 sets of initials that are listed in the indictment.

ie: Patient DS, Patient GR, Patient VL, Patient MG, Patient JG, Patient JL.

(otherwise, only other patients are 2 prescriptions for Patient AP, an appointment and DME for Patient UC).

Having reviewed over 100 cases, this is most likely the tip of the iceberg. You do not get to 500mil without a lot of fraud and abuse.
 
Having reviewed over 100 cases, this is most likely the tip of the iceberg. You do not get to 500mil without a lot of fraud and abuse.
So, $500 mil billed, for 5 docs would be $100 mil per doc.
It was over 5 years, so that would equal $20 mil billed per doc, per year. If you collect approx 1/3 of that, then you've got $6.7 million per doc, per year, collected, which is over 10 times what MGMA is, for IPM. That is a helluva lotta cheese.
 
fwiw
more info. for 2015:
Backos Eric 11207 prescriptions, 5301 opioid
Edu Ganiu 3610 prescriptions, 1663 opioid
Russo Christopher 3527 prescriptions, 2259 opioid
Kufner Ronald 2478 prescriptions, 1062 opioid
(none for Lewis that year).

numbers for 2016 seem similar:
Backos 9220/4255
edu 5032/2369
russo 3291/1784
kufner 4536/2027
 
1. Me
2. DRusso
3. Ligament
4. SSDoc
5. Hyperalgesia
6. Doctodd
7. Ductape
8. Taus
9. Lonelobo
10. axm (come back)
11. Algos
12. RInoo
13. AMPA
14. pastafan
15. Tenesma
16. many, many others.

This is like realizing the day after Christmas that Grandma forgot to get you a gift.
 
So how is that war on opiates working out?

Sessions: Opioid Prescriptions at 18-Year Low
Well, the Feds have lowered their target measure of prescriptions, they still have an easy scapegoat in a white coat that's easy to flog for the purpose of making the media thing they're addressing the problem and China keeps sending enough fentanyl to America to kill 50,000 Americans per year, without having to fire a single shot. It couldn't work out any better, if you're Satan.
 
Didn’t Sessions get fired?
Yeah, he's gone. It's some guy named Whitaker now, with William Barr, George Bush Sr's old AG on deck to be his permanent replacement.
 
Oh, it wasn't an error. It was protectionism of nursing by an incompetent nursing board that lacks the training or fundamental understanding of prescribing opioids. The nurse was out of control- the nursing board intentionally turned a blind eye to this incredibly dangerous prescribing because they lack basic knowledge. They should not be allowed to discipline nurse practitioners who are out of control. This duty needs to fall to those with education in opioids.
 
  • Like
Reactions: 1 users
Oh, it wasn't an error. It was protectionism of nursing by an incompetent nursing board that lacks the training or fundamental understanding of prescribing opioids. The nurse was out of control- the nursing board intentionally turned a blind eye to this incredibly dangerous prescribing because they lack basic knowledge. They should not be allowed to discipline nurse practitioners who are out of control. This duty needs to fall to those with education in opioids.

Anyone who cares about patient safety and physician autonomy should start attending their county and state medical society meetings and advocate for responsible scope of practice legislation.

Letter to the editor: Nurse practitioners & doctors

LETTER TO THE EDITOR | Monday, Dec. 24, 2018, 10:03 a.m.

While I respect Catherine Grant and nurse practitioners (NPs) who care for Pennsylvanians in rural areas, I disagree with the solution she proposed in her op-ed “Please, let nurse practitioners serve patients” (Dec. 8, TribLIVE).

Grant suggests that Pennsylvanians will gain better access to care by removing a state law that requires NPs to collaborate with physicians. States that have granted independent practice to NPs continue to struggle with access issues. Those states did not experience a sudden surge in additional NPs in rural areas.

In addition, nothing in current law keeps NPs from practicing to the fullest extent of their training. A collaborative agreement with a medical doctor is not a burden, but rather an assurance of greater expertise immediately available in the care of patients.

Case in point: Grant already owns her own health center. She can prescribe medications, order diagnostic tests and manage patients with chronic illnesses. As her story demonstrates, she’s already practicing to the fullest extent of her training and making a difference in her community.

Finally, when polled, a majority of Pennsylvanians say physicians should be immediately available when being treated by an NP.

The question our elected leaders need to ask is whether they support removing physicians from health care teams as the nurses suggest. We believe that’s the last thing patients want.

Dr. Lawrence John

Aspinwall

The writer is a family physician and president-elect of the Pennsylvania Medical Society.
 
I don’t know if resistance will stop the NP organizations. They are too well coordinated...


But..

One simple solution - have any scripts written by an N P require a PA that requires “physician “ approval. Can be a consultant. Insurance companies should jump on any rules that decrease prescribing...
 
Examining CDC’s State-by-State Data on Drug and Opioid Overdose Deaths

2017 CDC data shows about 11900 overdose deaths from Rx opioids. How many of these were patients taking meds as prescribed by the prescribing physician?

Crocodiles kill 1000 people per year. Unsure if we are directly responsible for more deaths from Rx to our patients than crocodiles?
 
they are from Rx opioids.

ie prescriptions from doctors. not illicits shipped from overseas.

you can deflect blame for the illicits, but the medical community owns these deaths. if you write a prescription and it is diverted to someone else who kills himself, and while one can claim"I didn't give it to that victim", but without the prescription opioid out there, that death never occurs.

aren't you concerned about diversion? rhetorical question here, but don't you fire patients if they have a negative UDS and you so much as think they are diverting?
 
they are from Rx opioids.

ie prescriptions from doctors. not illicits shipped from overseas.

you can deflect blame for the illicits, but the medical community owns these deaths. if you write a prescription and it is diverted to someone else who kills himself, and while one can claim"I didn't give it to that victim", but without the prescription opioid out there, that death never occurs.

aren't you concerned about diversion? rhetorical question here, but don't you fire patients if they have a negative UDS and you so much as think they are diverting?

Wouldn't you remind them of the promise they made in their Pain Treatment Covenant that they made with you? I know one pain specialist who makes his patients swear on the Holy Bible that they won't divert or overuse their medications, videotapes the promise, and puts the MP4 in the medical chart.

If someone doesn't keep their promise, then they should be held accountable.
 
  • Like
Reactions: 1 user
they are from Rx opioids.

ie prescriptions from doctors. not illicits shipped from overseas.

you can deflect blame for the illicits, but the medical community owns these deaths. if you write a prescription and it is diverted to someone else who kills himself, and while one can claim"I didn't give it to that victim", but without the prescription opioid out there, that death never occurs.

aren't you concerned about diversion? rhetorical question here, but don't you fire patients if they have a negative UDS and you so much as think they are diverting?

Nope, I fire meds, not patients. If I suspect criminal behavior, we get a LEO consult.
 
Opioids are killing more children and teens, too, study says

released today.

Opioids are killing more children and teens, too, study says
Posted 11:01 am, December 28, 2018, by CNN Wires



Nearly 9,000 pediatric deaths were attributed to opioids from 1999 through 2016, according to a report published Friday in the journal JAMA Network Open.



A growing number of children and adolescents in the United States are dying from opioid poisonings, a new study shows.

Nearly 9,000 pediatric deaths were attributed to opioids from 1999 through 2016, according to a report published Friday in the journal JAMA Network Open. During that 18-year span, the mortality rate for youth due to opioid poisonings nearly tripled.

“What began more than 2 decades ago as a public health problem primarily among young and middle-aged white males is now an epidemic of prescription and illicit opioid abuse that is taking a toll on all segments of US society, including the pediatric population,” researchers wrote. “Millions of children and adolescents are now routinely exposed in their homes, schools and communities to these potent and addictive drugs.”

Research released earlier this year in the journal Pediatrics showed that the number of children admitted to hospitals for opioid overdoses nearly doubled from 2004 to 2015.

This new study set out to examine who’s dying.

Looking at the numbers
Of the 8,986 children and adolescents who died from opioid poisonings over the 18-year period, 6,567 (about 73%) were male and 7,921 (about 88%) were adolescents ranging in age from 15 to 19. Among the 15- to 19-year-olds, 3,050 deaths also involved one or more other substances, such as benzodiazepines, cocaine, alcohol or antidepressants.

Nearly 7% of deaths were children ages zero to 4, about 4% were 10 to 14 and about 1% were ages 5 to 9.

Non-Hispanic white children and adolescents made up the majority, nearly 80%, of those who died. Hispanic youth accounted for more than 10% of the deaths, while non-Hispanic black youth were about 7% of the death total.

Prescription opioids accounted for 73% of the deaths, but heroin killed nearly 1,900 (about 24%) of those age 15 to 19.

The bulk of these opioid deaths, nearly 81% of them, were unintentional. Five percent were suicides and 2.4% were homicides. But for children younger than 5, nearly a quarter of the deaths were labeled homicides; among infants, it was closer to 35%.

The importance of place
Where children and adolescents died was also examined, since most other research has focused on results from emergency room visits and hospitalizations, the researchers said.

They pointed to one study that determined that about 2,000 children a year were hospitalized for opioid poisoning between 1997 and 2012, and “a small number,” about 30 each year, died while hospitalized.

The new report, however, puts the number of deaths per year at closer to 500. The new study’s authors found that most deaths happened away from a medical setting, with 38% occurring in homes.

The researchers relied on data from death certificates, which they acknowledged might include some misclassifications of cause and manner of death.

But even with that possible limitation, they wrote, the problem for youth will likely grow “unless legislators, public health officials, clinicians and parents take a wider view of the opioid crisis and implement protective measures that are pediatric-specific and family-centered.”

Last year, there were more than 70,000 drug overdose deaths in the United States, according to a recent report from the US Centers for Disease Control and Prevention, and opioids were involved in 67.8% of those deaths.
for this group, prescription opioids remain a primary contributor

actual article:
US National Trends in Pediatric Deaths From Prescription and Illicit Opioids, 1999-2016
 
Last edited:

Stupid article. Does not appear these kids were prescribed opiates. Looks like drug abuse starts about age 10. We knew that. Looks like kids will abuse drugs they can get easiest. We knew that.

Are you going to say we need to stop treating our patients because kids are in the house? Going after our guns first? Or next?
You must be treating an entirely different level of stupid than I get to see. Meds are to be locked up for safe keeping.
 
yes, the kids were not prescribed the opioids, but they took what they could get a hold of - those of their parents and their friend's parents. kids less than 12 are rarely out on the streets buying the drugs.


and yes, i am saying that if a patient has young kids in their house, we have the responsibility to consider this when you write for the hundreds of vicodins and percocets that are going to sit in the house, especially medicine cabinets. you should be determining if a patient is trustworthy enough to keep meds locked up and safe, and kept away from their kids, or we should not be prescribing. if there are adolescents in the house, i factor in to this whether to prescribe anything.

(and since you will ask - yes, i have specifically asked patients to bring in pictures of the lock box that they supposedly keep their pills in, along with the pill bottle with label visible with their names.)
 
  • Like
Reactions: 1 users
yes, the kids were not prescribed the opioids, but they took what they could get a hold of - those of their parents and their friend's parents. kids less than 12 are rarely out on the streets buying the drugs.


and yes, i am saying that if a patient has young kids in their house, we have the responsibility to consider this when you write for the hundreds of vicodins and percocets that are going to sit in the house, especially medicine cabinets. you should be determining if a patient is trustworthy enough to keep meds locked up and safe, and kept away from their kids, or we should not be prescribing. if there are adolescents in the house, i factor in to this whether to prescribe anything.

(and since you will ask - yes, i have specifically asked patients to bring in pictures of the lock box that they supposedly keep their pills in, along with the pill bottle with label visible with their names.)

I think we can agree that the opioid death rate is primarily, either directly or indirectly, due to the abundance of prescription opioids over the past 20 years.

Many become addicted to, and then overdose on the opioids that were prescribed to them or to others. Others become addicted to prescription opioids, and then overdose on fentanyl/heroin when they can no longer obtain prescription opioids.

What will eventually turn this around are harm reduction clinics, accessibility of MAT, and acceptance by most physicians in this country that in general, opioids should not be started in working-aged adults for chronic non-malignant pain.
 
Last edited:
  • Like
Reactions: 3 users
Couldn’t agree more “opioids should not be started on in working aged adults for chronic non malignant pain”.
 
  • Like
Reactions: 2 users
What will eventually turn this around are harm reduction clinics, accessibility of MAT, and acceptance by most physicians in this country that in general, opioids should not be started in working-aged adults for chronic non-malignant pain.
I agree. My policy for the last 5 + years has been exactly that. Not to start anyone on opiates, who's not on them, for chronic non-cancer/non-palliative pain. The problem is, so many other people do (PCPs, surgeons, ED) and by the time they get to us, so, so many are already on them. Then it becomes, "Don't prescribe above 90 MED, don't dose escalate, look for reasons to decrease or discontinue and monitor, monitor, monitor." We need to get the PCPs, surgeons and ED also on board to not start opiates. Once you start them they never want to stop.
 
  • Like
Reactions: 3 users
Top